1. Home
  2. PRPO vs AIMD Comparison

PRPO vs AIMD Comparison

Compare PRPO & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • AIMD
  • Stock Information
  • Founded
  • PRPO N/A
  • AIMD 1984
  • Country
  • PRPO United States
  • AIMD United States
  • Employees
  • PRPO N/A
  • AIMD N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • AIMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRPO Industrials
  • AIMD Health Care
  • Exchange
  • PRPO Nasdaq
  • AIMD Nasdaq
  • Market Cap
  • PRPO 9.9M
  • AIMD 8.5M
  • IPO Year
  • PRPO N/A
  • AIMD N/A
  • Fundamental
  • Price
  • PRPO $6.65
  • AIMD $0.62
  • Analyst Decision
  • PRPO
  • AIMD
  • Analyst Count
  • PRPO 0
  • AIMD 0
  • Target Price
  • PRPO N/A
  • AIMD N/A
  • AVG Volume (30 Days)
  • PRPO 6.6K
  • AIMD 1.3M
  • Earning Date
  • PRPO 03-28-2025
  • AIMD 03-07-2025
  • Dividend Yield
  • PRPO N/A
  • AIMD N/A
  • EPS Growth
  • PRPO N/A
  • AIMD N/A
  • EPS
  • PRPO N/A
  • AIMD N/A
  • Revenue
  • PRPO $17,411,000.00
  • AIMD $40,633.00
  • Revenue This Year
  • PRPO $75.18
  • AIMD N/A
  • Revenue Next Year
  • PRPO N/A
  • AIMD N/A
  • P/E Ratio
  • PRPO N/A
  • AIMD N/A
  • Revenue Growth
  • PRPO 31.31
  • AIMD N/A
  • 52 Week Low
  • PRPO $4.31
  • AIMD $0.40
  • 52 Week High
  • PRPO $7.20
  • AIMD $3.10
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 63.80
  • AIMD 48.56
  • Support Level
  • PRPO $6.52
  • AIMD $0.57
  • Resistance Level
  • PRPO $6.90
  • AIMD $0.87
  • Average True Range (ATR)
  • PRPO 0.27
  • AIMD 0.09
  • MACD
  • PRPO 0.03
  • AIMD -0.02
  • Stochastic Oscillator
  • PRPO 89.90
  • AIMD 17.45

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: